Proposed Data Collection Submitted for Public Comment and Recommendations, 55815-55817 [2022-19562]
Download as PDF
<![CDATA[
Federal Register / Vol. 87, No. 175 / Monday, September 12, 2022 / Notices
Centers for Disease Control and
Prevention
[60Day–22–1317; Docket No. CDC–2022–
0107]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a continuing information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled, National
Healthcare Safety Network (NHSN)
Coronavirus (COVID–19) Surveillance
in Healthcare Facilities. Data collected
through this version of NHSN is
intended to inform the federal
government’s understanding of disease
patterns, including the changing burden
of disease, and develop policies for
prevention and control of problems
related to COVID–19.
DATES: CDC must receive written
comments on or before November 14,
2022.
SUMMARY:
You may submit comments,
identified by Docket No. CDC–2022–
0107 by either of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
lotter on DSK11XQN23PROD with NOTICES1
ADDRESSES:
VerDate Sep<11>2014
17:06 Sep 09, 2022
Jkt 256001
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7570; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
FOR FURTHER INFORMATION CONTACT:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Proposed Project
National Healthcare Safety Network
(NHSN) Coronavirus (COVID–19)
Surveillance in Healthcare Facilities
(OMB Control No. 0920–1317, Exp. 1/
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
55815
31/2024)—Revision—National Center
for Emerging and Zoonotic Infectious
Diseases (NCEZID), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
Hospitals are key partners in the U.S.
response to COVID–19. The response is
locally executed, state managed, and
federally supported. At the federal level,
the U.S. Department of Health & Human
Services (HHS) COVID–19 Response
Function, the White House Coronavirus
Response Team, and the Centers for
Disease Control & Prevention (CDC)
COVID–19 Response Function work
together to support the effective
operations of the American healthcare
system. This collection initially began
in March 2020 through a letter from
then Vice President Pence to the
nation’s 4,700 hospitals, asking them to
submit data daily on the number of
patients tested for COVID–19, as well as
information on bed capacity and
requirements for other supplies.
(https://www.cms.gov/files/document/
32920-hospital-letter-vice-presidentpence.pdf). CDC’s National Healthcare
Safety Network (NHSN) COVID–19
Module (OMB Control No. 0920–1290)
was approved March 26, 2020 for the
collection of hospital COVID–19 data.
The NHSN COVID–19 Module also
collects COVID–19 data from long-term
care facilities and dialysis centers
(collection was later revised and given
OMB Control No. 0920–1317).
Beginning July 2020, at the request of
the White House Coronavirus Task
Force, the collection of COVID–19 data
from hospitals was moved to HHS/
ASPR and housed in the TeleTracking
portal. Collection of data from the other
facilities remained with CDC under the
NHSN COVID–19 Module.
Beginning in mid-December 2022,
NHSN will resume the responsibility for
collection of COVID–19 hospital data
and will incorporate the TeleTracking
data collection into 0920–1317. The
purpose of this Revision request is to
move the burden associated with
collection of COVID–19 related data
from hospitals to the CDC NHSN
COVID–19 module. CDC requests OMB
approval for an estimated 8,467,590
annual burden hours. 3,290,200 in
burden hours will be added to this
previous collection for the addition of
the TeleTracking portal. There are no
additional costs to respondents other
than their time to participate.
E:\FR\FM\12SEN1.SGM
12SEN1
55816
Federal Register / Vol. 87, No. 175 / Monday, September 12, 2022 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
LTCF personnel ................................
NHSN and Secure Access Management Services (SAMS) enrollment.
COVID–19 Module, Long Term Care
Facility: Resident Impact and Facility Capacity form (57.144).
COVID–19 Module, Long Term Care
Facility: Resident Impact and Facility Capacity form (57.144).
COVID–19 Module, Long Term Care
Facility: Resident Impact and Facility Capacity form (57.144).
COVID–19 Module, Long Term Care
Facility Resident Impact and Facility Capacity form (57.144) (retrospective data entry).
COVID–19 Module, Long Term Care
Facility Resident Impact and Facility Capacity form (57.144) (retrospective data entry).
COVID–19 Module, Long Term Care
Facility Resident Impact and Facility Capacity form (57.144) (retrospective data entry).
COVID–19 Module, Long Term Care
Facility: Staff and Personnel Impact form (57.145).
COVID–19 Module, Long Term Care
Facility: Staff and Personnel Impact form (57.145).
COVID–19 Module, Long Term Care
Facility: Staff and Personnel Impact form (57.145).
COVID–19 Module, Long Term Care
Facility Staff and Personnel Impact form (57.145) (retrospective
data entry).
COVID–19 Module, Long Term Care
Facility Staff and Personnel Impact form (57.145) (retrospective
data entry).
COVID–19 Module, Long Term Care
Facility Staff and Personnel Impact form (57.145) (retrospective
data entry).
COVID–19 Module, Long-Term Care
Facility: Resident Therapeutics
(57.158).
COVID–19 Module, Long-Term Care
Facility: Resident Therapeutics
(57.158).
COVID–19 Module, Long-Term Care
Facility: Resident Therapeutics
(57.158).
LTCF VA Resident COVID–19
Event Form.
LTCF VA Staff and Personnel
COVID–19 Event Form.
Weekly Healthcare Personnel
COVID–19 Vaccination Cumulative Summary.
Weekly Resident COVID–19 Vaccination Cumulative Summary for
Long-Term Care Facilities.
Weekly Patient COVID–19 Vaccination Cumulative Summary for Dialysis Facilities.
Monthly Reporting Plan form for
Long-term Care Facilities.
LTCF personnel ................................
Business and financial operations
occupations.
State and local health department
occupations.
LTCF personnel ................................
Business and financial operations
occupations.
State and local health department
occupations.
LTCF personnel ................................
Business and financial operations
occupations.
State and local health department
occupations.
LTCF personnel ................................
Business and financial operations
occupations.
State and local health department
occupations.
LTCF personnel ................................
Business and financial operations
occupations.
State and local health department
occupations.
LTCF personnel ................................
LTCF personnel ................................
Facility personnel ..............................
lotter on DSK11XQN23PROD with NOTICES1
Number of
respondents
Type of respondent
LTCF personnel ................................
Microbiologist (IP) .............................
LTCF personnel ................................
VerDate Sep<11>2014
17:06 Sep 09, 2022
Jkt 256001
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total
burden
hours
11,500
1
60/60
11,500
11,621
52
40/60
402,861
1,870
52
40/60
64,827
1,870
52
40/60
64,827
5,811
1
40/60
3,874
935
1
40/60
623
935
1
40/60
623
11,621
52
15/60
151,073
1,870
52
15/60
24,310
1,870
52
15/60
24,310
5,811
1
15/60
1,453
935
1
15/60
234
935
1
15/60
234
11,621
52
10/60
100,715
1,870
52
10/60
16,207
1,870
52
10/60
16,207
188
36
35/60
3,948
188
36
20/60
2,256
12,600
52
90/60
982,800
16,864
52
75/60
1,096,160
7,700
52
75/100
500,500
16,864
9
5/60
12,648
E:\FR\FM\12SEN1.SGM
12SEN1
55817
Federal Register / Vol. 87, No. 175 / Monday, September 12, 2022 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Form name
Microbiologist (IP) .............................
Healthcare Personnel Safety Monthly Reporting Plan—completed by
Dialysis Facilities.
Healthcare Personnel Safety Monthly Reporting Plan—completed by
Inpatient Psychiatric Facilities.
COVID–19 Dialysis Component
Form.
NHSN COVID–19 Hospital Module
NHSN COVID–19 Hospital Module
Microbiologist (IP) .............................
Microbiologist (IP) .............................
Hospitals ...........................................
Infusion Centers and Outpatient
Clinics reporting Inventory & use
of therapeutics (MABs).
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–19562 Filed 9–9–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Award of a Single-Source
Cooperative Agreement To Fund Addis
Ababa City Administration Health
Bureau of Ethiopia
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), located
within the Department of Health and
Human Services (HHS), announces the
award of approximately $10,000,000 for
Year 1 of funding to the Addis Ababa
City Administration Health Bureau of
Ethiopia (AACAHB) to ensure
continuity of quality comprehensive
HIV/AIDS prevention, care, and
treatment services for controlling the
HIV epidemic activities in Addis Ababa
City Administration of Ethiopia. The
award will help the city close gaps to
achieve the 95–95–95 goals (95% of
HIV-positive individuals knowing their
status, 95% of those receiving ART
[Antiretroviral therapy], and 95% of
those achieving viral suppression) and
reach HIV epidemic control. Funding
amounts for years 2–5 will be set at
continuation.
SUMMARY:
lotter on DSK11XQN23PROD with NOTICES1
Number of
respondents
Type of respondent
The period for this award will be
September 30, 2022 through September
29, 2027.
DATES:
VerDate Sep<11>2014
17:06 Sep 09, 2022
Jkt 256001
5/60
5,775
394
12
5/60
394
4,900
104
20/60
169,867
6,000
400
365
52
90/60
15/60
3,285,000
5,200
Summary of the Award
Recipient: Addis Ababa City
Administration Health Bureau of
Ethiopia.
Purpose of the Award: The purpose of
this award is to ensure continuity of
quality comprehensive HIV/AIDS
prevention, care, and treatment services
for controlling the HIV epidemic
activities in Addis Ababa City
Administration of Ethiopia. This NOFO
will help the city close gaps to achieve
the 95–95–95 goals and reach HIV
epidemic control.
Amount of Award: The approximate
year 1 funding amount will be
$10,000,000 in Federal Fiscal Year
(FFY) 2022 funds, subject to the
availability of funds. Funding amounts
for years 2–5 will be set at continuation.
Period of Performance: September 30,
2022 through September 29, 2027.
Fmt 4703
Sfmt 4703
Total
burden
hours
9
Tesfaye Desta, Center for Global Health,
Centers for Disease Control and
Prevention, U.S. Embassy—Addis
Ababa, Entoto Road, Addis Ababa,
Ethiopia, Telephone: 800–232–6348,
Email: hmz4@cdc.gov.
SUPPLEMENTARY INFORMATION: The
single-source award will implement
prevention, testing and counselling,
prevention of mother to child
transmission, care and treatment,
laboratory, Strategic Information (M&E,
Surveillance, HIS), TB/HIV and other
public health need affecting HIV/AIDS
programming like COVID in the capital
city of Ethiopia, Addis Ababa.
The purpose of this award is to
continue supporting the strengthening
of public health response and programs,
including but not limited to HIV/AIDS,
in the Addis Ababa City. AACAHB is
the only government entity with a legal
authority and mandate to plan, manage,
administer, and coordinate all healthrelated activities in the city.
Frm 00039
Average
burden per
response
(in hours)
7,700
FOR FURTHER INFORMATION CONTACT:
PO 00000
Number of
responses per
respondent
Authority: Public Law 108–25 (the
United States Leadership Against HIV
AIDS, Tuberculosis and Malaria Act of
2003).
Dated: September 6, 2022.
Terrance Perry,
Chief Grants Management Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2022–19566 Filed 9–9–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)–
RFA–OH–22–003, Occupational Safety
and Health Training Project Grants
(TPG).
Date: December 6, 2022.
Time: 1:00 p.m.–4:00 p.m., EST.
E:\FR\FM\12SEN1.SGM
12SEN1
]]>Agencies
[Federal Register Volume 87, Number 175 (Monday, September 12, 2022)]
[Notices]
[Pages 55815-55817]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-19562]
[[Page 55815]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-22-1317; Docket No. CDC-2022-0107]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
federal agencies the opportunity to comment on a continuing information
collection, as required by the Paperwork Reduction Act of 1995. This
notice invites comment on a proposed information collection project
titled, National Healthcare Safety Network (NHSN) Coronavirus (COVID-
19) Surveillance in Healthcare Facilities. Data collected through this
version of NHSN is intended to inform the federal government's
understanding of disease patterns, including the changing burden of
disease, and develop policies for prevention and control of problems
related to COVID-19.
DATES: CDC must receive written comments on or before November 14,
2022.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2022-
0107 by either of the following methods:
Federal eRulemaking Portal: www.regulations.gov. Follow
the instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to www.regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (www.regulations.gov) or by U.S. mail to the address listed
above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570;
Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
National Healthcare Safety Network (NHSN) Coronavirus (COVID-19)
Surveillance in Healthcare Facilities (OMB Control No. 0920-1317, Exp.
1/31/2024)--Revision--National Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Hospitals are key partners in the U.S. response to COVID-19. The
response is locally executed, state managed, and federally supported.
At the federal level, the U.S. Department of Health & Human Services
(HHS) COVID-19 Response Function, the White House Coronavirus Response
Team, and the Centers for Disease Control & Prevention (CDC) COVID-19
Response Function work together to support the effective operations of
the American healthcare system. This collection initially began in
March 2020 through a letter from then Vice President Pence to the
nation's 4,700 hospitals, asking them to submit data daily on the
number of patients tested for COVID-19, as well as information on bed
capacity and requirements for other supplies. (https://www.cms.gov/files/document/32920-hospital-letter-vice-president-pence.pdf). CDC's
National Healthcare Safety Network (NHSN) COVID-19 Module (OMB Control
No. 0920-1290) was approved March 26, 2020 for the collection of
hospital COVID-19 data. The NHSN COVID-19 Module also collects COVID-19
data from long-term care facilities and dialysis centers (collection
was later revised and given OMB Control No. 0920-1317). Beginning July
2020, at the request of the White House Coronavirus Task Force, the
collection of COVID-19 data from hospitals was moved to HHS/ASPR and
housed in the TeleTracking portal. Collection of data from the other
facilities remained with CDC under the NHSN COVID-19 Module.
Beginning in mid-December 2022, NHSN will resume the responsibility
for collection of COVID-19 hospital data and will incorporate the
TeleTracking data collection into 0920-1317. The purpose of this
Revision request is to move the burden associated with collection of
COVID-19 related data from hospitals to the CDC NHSN COVID-19 module.
CDC requests OMB approval for an estimated 8,467,590 annual burden
hours. 3,290,200 in burden hours will be added to this previous
collection for the addition of the TeleTracking portal. There are no
additional costs to respondents other than their time to participate.
[[Page 55816]]
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response Total burden
respondents respondent (in hours) hours
----------------------------------------------------------------------------------------------------------------
LTCF personnel................ NHSN and Secure 11,500 1 60/60 11,500
Access
Management
Services (SAMS)
enrollment.
LTCF personnel................ COVID-19 Module, 11,621 52 40/60 402,861
Long Term Care
Facility:
Resident Impact
and Facility
Capacity form
(57.144).
Business and financial COVID-19 Module, 1,870 52 40/60 64,827
operations occupations. Long Term Care
Facility:
Resident Impact
and Facility
Capacity form
(57.144).
State and local health COVID-19 Module, 1,870 52 40/60 64,827
department occupations. Long Term Care
Facility:
Resident Impact
and Facility
Capacity form
(57.144).
LTCF personnel................ COVID-19 Module, 5,811 1 40/60 3,874
Long Term Care
Facility
Resident Impact
and Facility
Capacity form
(57.144)
(retrospective
data entry).
Business and financial COVID-19 Module, 935 1 40/60 623
operations occupations. Long Term Care
Facility
Resident Impact
and Facility
Capacity form
(57.144)
(retrospective
data entry).
State and local health COVID-19 Module, 935 1 40/60 623
department occupations. Long Term Care
Facility
Resident Impact
and Facility
Capacity form
(57.144)
(retrospective
data entry).
LTCF personnel................ COVID-19 Module, 11,621 52 15/60 151,073
Long Term Care
Facility: Staff
and Personnel
Impact form
(57.145).
Business and financial COVID-19 Module, 1,870 52 15/60 24,310
operations occupations. Long Term Care
Facility: Staff
and Personnel
Impact form
(57.145).
State and local health COVID-19 Module, 1,870 52 15/60 24,310
department occupations. Long Term Care
Facility: Staff
and Personnel
Impact form
(57.145).
LTCF personnel................ COVID-19 Module, 5,811 1 15/60 1,453
Long Term Care
Facility Staff
and Personnel
Impact form
(57.145)
(retrospective
data entry).
Business and financial COVID-19 Module, 935 1 15/60 234
operations occupations. Long Term Care
Facility Staff
and Personnel
Impact form
(57.145)
(retrospective
data entry).
State and local health COVID-19 Module, 935 1 15/60 234
department occupations. Long Term Care
Facility Staff
and Personnel
Impact form
(57.145)
(retrospective
data entry).
LTCF personnel................ COVID-19 Module, 11,621 52 10/60 100,715
Long-Term Care
Facility:
Resident
Therapeutics
(57.158).
Business and financial COVID-19 Module, 1,870 52 10/60 16,207
operations occupations. Long-Term Care
Facility:
Resident
Therapeutics
(57.158).
State and local health COVID-19 Module, 1,870 52 10/60 16,207
department occupations. Long-Term Care
Facility:
Resident
Therapeutics
(57.158).
LTCF personnel................ LTCF VA Resident 188 36 35/60 3,948
COVID-19 Event
Form.
LTCF personnel................ LTCF VA Staff 188 36 20/60 2,256
and Personnel
COVID-19 Event
Form.
Facility personnel............ Weekly 12,600 52 90/60 982,800
Healthcare
Personnel COVID-
19 Vaccination
Cumulative
Summary.
LTCF personnel................ Weekly Resident 16,864 52 75/60 1,096,160
COVID-19
Vaccination
Cumulative
Summary for
Long-Term Care
Facilities.
Microbiologist (IP)........... Weekly Patient 7,700 52 75/100 500,500
COVID-19
Vaccination
Cumulative
Summary for
Dialysis
Facilities.
LTCF personnel................ Monthly 16,864 9 5/60 12,648
Reporting Plan
form for Long-
term Care
Facilities.
[[Page 55817]]
Microbiologist (IP)........... Healthcare 7,700 9 5/60 5,775
Personnel
Safety Monthly
Reporting Plan--
completed by
Dialysis
Facilities.
Microbiologist (IP)........... Healthcare 394 12 5/60 394
Personnel
Safety Monthly
Reporting Plan--
completed by
Inpatient
Psychiatric
Facilities.
Microbiologist (IP)........... COVID-19 4,900 104 20/60 169,867
Dialysis
Component Form.
Hospitals..................... NHSN COVID-19 6,000 365 90/60 3,285,000
Hospital Module.
Infusion Centers and NHSN COVID-19 400 52 15/60 5,200
Outpatient Clinics reporting Hospital Module.
Inventory & use of
therapeutics (MABs).
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2022-19562 Filed 9-9-22; 8:45 am]
BILLING CODE 4163-18-P
